{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:32:00Z","timestamp":1790184720642,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastric carcinogenesis is a multifactorial process described as a stepwise progression from non-active gastritis (NAG), chronic active gastritis (CAG), precursor lesions of gastric cancer (PLGC) and gastric adenocarcinoma. Gastric cancer (GC) 5-year survival rate is highly dependent upon stage of disease at diagnosis, which is based on endoscopy, biopsy and pathological examinations. Non-invasive GC biomarkers would facilitate its diagnosis at early stages leading to improved GC prognosis. We analyzed plasma samples collected from 80 patients diagnosed with NAG without<jats:italic>H. pylori<\/jats:italic>infection (NAG\u2212), CAG with<jats:italic>H. pylori<\/jats:italic>infection (CAG+), PLGC and GC. A panel of 208 metabolites including acylcarnitines, amino acids and biogenic amines, sphingolipids, glycerophospholipids, hexoses, and tryptophan and phenylalanine metabolites were quantified using two complementary quantitative approaches: Biocrates AbsoluteIDQ\u00aep180 kit and a LC-MS method designed for the analysis of 29 tryptophan pathway and phenylalanine metabolites. Significantly altered metabolic profiles were found in GC patients that allowing discrimination from NAG\u2212, CAG+ and PLGC patients. Pathway analysis showed significantly altered tryptophan and nitrogen metabolic pathways (FDR P\u2009&lt;\u20090.01). Three metabolites (histidine, tryprophan and phenylacetylglutamine) discriminated between non-GC and GC groups. These metabolic signatures open new possibilities to improve surveillance of PLGC patients using a minimally invasive blood analysis.<\/jats:p>","DOI":"10.1038\/s41598-017-17921-x","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T10:35:01Z","timestamp":1513161301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Plasma sample based analysis of gastric cancer progression using targeted metabolomics"],"prefix":"10.1038","volume":"7","author":[{"given":"Sergio","family":"Lario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Ram\u00edrez-L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sanjuan-Herr\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brunet-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Pericay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Gombau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Junquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Quint\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"17921_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer J. Int. Cancer 136, E359\u2013386 (2015).","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"17921_CR2","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/onc.2014.187","volume":"34","author":"E Bess\u00e8de","year":"2015","unstructured":"Bess\u00e8de, E., Dubus, P., M\u00e9graud, F. & Varon, C. Helicobacter pylori infection and stem cells at the origin of gastric cancer. Oncogene 34, 2547\u20132555 (2015).","journal-title":"Oncogene"},{"key":"17921_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.gastro.2015.09.004","volume":"150","author":"M Amieva","year":"2016","unstructured":"Amieva, M. & Peek, R. M. Pathobiology of Helicobacter pylori-Induced Gastric Cancer. Gastroenterology 150, 64\u201378 (2016).","journal-title":"Gastroenterology"},{"key":"17921_CR4","first-page":"3554","volume":"48","author":"P Correa","year":"1988","unstructured":"Correa, P. A human model of gastric carcinogenesis. Cancer Res. 48, 3554\u20133560 (1988).","journal-title":"Cancer Res."},{"key":"17921_CR5","first-page":"6735","volume":"52","author":"P Correa","year":"1992","unstructured":"Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process\u2013First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735\u20136740 (1992).","journal-title":"Cancer Res."},{"key":"17921_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00042737-200608000-00004","volume":"18","author":"YK Tan","year":"2006","unstructured":"Tan, Y. K. & Fielding, J. W. L. Early diagnosis of early gastric cancer. Eur. J. Gastroenterol. Hepatol. 18, 821\u2013829 (2006).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"17921_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15430\/JCP.2015.20.1.25","volume":"20","author":"YH Park","year":"2015","unstructured":"Park, Y. H. & Kim, N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J. Cancer Prev. 20, 25\u201340 (2015).","journal-title":"J. Cancer Prev."},{"key":"17921_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1013713905833","volume":"48","author":"O Fiehn","year":"2002","unstructured":"Fiehn, O. Metabolomics\u2013the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155\u2013171 (2002).","journal-title":"Plant Mol. Biol."},{"key":"17921_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.aca.2015.02.012","volume":"879","author":"PS Gromski","year":"2015","unstructured":"Gromski, P. S. et al. A tutorial review: Metabolomics and partial least squares-discriminant analysis \u2013 a marriage of convenience or a shotgun wedding. Anal. Chim. Acta 879, 10\u201323 (2015).","journal-title":"Anal. Chim. Acta"},{"key":"17921_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"17921_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin, J. L., Serkova, N. J. & Gail Eckhardt, S. Clinical Applications of Metabolomics in Oncology: A Review. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 15, 431\u2013440 (2009).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"17921_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/metabo3030552","volume":"3","author":"RD Beger","year":"2013","unstructured":"Beger, R. D. A Review of Applications of Metabolomics in Cancer. Metabolites 3, 552\u2013574 (2013).","journal-title":"Metabolites"},{"key":"17921_CR13","doi-asserted-by":"crossref","unstructured":"Vermeersch, K. A. & Styczynski, M. P. Applications of metabolomics in cancer research. J. Carcinog. 12, (2013).","DOI":"10.4103\/1477-3163.113622"},{"key":"17921_CR14","first-page":"88","volume":"50","author":"S Ben-Haim","year":"2009","unstructured":"Ben-Haim, S. & Ell, P. 18F-FDG PET and PET\/CT in the evaluation of cancer treatment response. J. Nucl. Med. Off. Publ. Soc. Nucl. Med. 50, 88\u201399 (2009).","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"17921_CR15","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"17921_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2016.04.025","volume":"100","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli, M. & Frezza, C. Oncometabolites: Unconventional triggers of oncogenic signalling cascades. Free Radic. Biol. Med. 100, 175\u2013181 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"17921_CR17","first-page":"149","volume":"12","author":"RD Beger","year":"2016","unstructured":"Beger, R. D. et al. Metabolomics enables precision medicine: \u2018A White Paper, Community Perspective\u2019. Metabolomics Off. J. Metabolomic Soc. 12, 149 (2016).","journal-title":"Metabolomics Off. J. Metabolomic Soc."},{"issue":"Suppl 4","key":"17921_CR18","doi-asserted-by":"publisher","first-page":"S736","DOI":"10.1245\/s10434-014-3886-0","volume":"21","author":"J Jung","year":"2014","unstructured":"Jung, J. et al. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling. Ann. Surg. Oncol. 21(Suppl 4), S736\u2013742 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"17921_CR19","doi-asserted-by":"crossref","first-page":"87496","DOI":"10.18632\/oncotarget.11754","volume":"7","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis. Oncotarget 7, 87496\u201387510 (2016).","journal-title":"Oncotarget"},{"key":"17921_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/bjc.2015.414","volume":"114","author":"AW Chan","year":"2016","unstructured":"Chan, A. W. et al. 1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer. Br. J. Cancer 114, 59\u201362 (2016).","journal-title":"Br. J. Cancer"},{"key":"17921_CR21","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/j.1440-1746.2011.06724.x","volume":"26","author":"L Yu","year":"2011","unstructured":"Yu, L. et al. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry. J. Gastroenterol. Hepatol. 26, 1290\u20131297 (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"17921_CR22","doi-asserted-by":"publisher","first-page":"e24143","DOI":"10.1371\/journal.pone.0024143","volume":"6","author":"Y Miyagi","year":"2011","unstructured":"Miyagi, Y. et al. Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection. PLoS ONE 6, e24143 (2011).","journal-title":"PLoS ONE"},{"key":"17921_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0408-1","volume":"13","author":"Y Gu","year":"2015","unstructured":"Gu, Y. et al. Perioperative dynamics and significance of amino acid profiles in patients with cancer. J. Transl. Med. 13, 35 (2015).","journal-title":"J. Transl. Med."},{"key":"17921_CR24","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1021\/acs.jproteome.6b00281","volume":"15","author":"J Kuligowski","year":"2016","unstructured":"Kuligowski, J. et al. Metabolomic Analysis of Gastric Cancer Progression within the Correa\u2019s Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry. J. Proteome Res. 15, 2729\u20132738 (2016).","journal-title":"J. Proteome Res."},{"issue":"Suppl 2","key":"17921_CR25","first-page":"S1","volume":"41","author":"Guidelines for clinical trials in Helicobacter pylori infection","year":"1997","unstructured":"Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut 41(Suppl 2), S1\u20139 (1997).","journal-title":"Gut"},{"key":"17921_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to MultipleTesting. . J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":". J. R. Stat. Soc. Ser. B Methodol."},{"key":"17921_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"RA van den Berg","year":"2006","unstructured":"van den Berg, R. A., Hoefsloot, H. C., Westerhuis, J. A., Smilde, A. K. & van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7, 142 (2006).","journal-title":"BMC Genomics"},{"key":"17921_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11306-011-0330-3","volume":"8","author":"E Szymanska","year":"2012","unstructured":"Szymanska, E., Saccenti, E., Smilde, A. K. & Westerhuis, J. A. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics 8, 3\u201316 (2012).","journal-title":"Metabolomics"},{"key":"17921_CR29","doi-asserted-by":"publisher","unstructured":"Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0\u2014making metabolomics more meaningful. Nucleic Acids Res. gkv380, https:\/\/doi.org\/10.1093\/nar\/gkv380 (2015).","DOI":"10.1093\/nar\/gkv380"},{"key":"17921_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11306-013-0598-6","volume":"10","author":"E Saccenti","year":"2014","unstructured":"Saccenti, E., Hoefsloot, H. C. J., Smilde, A. K., Westerhuis, J. A. & Hendriks, M. M. W. B. Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics 10, 361\u2013374 (2014).","journal-title":"Metabolomics"},{"key":"17921_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.chemolab.2004.12.011","volume":"78","author":"I-G Chong","year":"2005","unstructured":"Chong, I.-G. & Jun, C.-H. Performance of some variable selection methods when multicollinearity is present. Chemom. Intell. Lab. Syst. 78, 103\u2013112 (2005).","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"17921_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11306-005-1107-3","volume":"1","author":"D Camacho","year":"2005","unstructured":"Camacho, D., Fuente, Adela & Mendes, P. The origin of correlations in metabolomics data. Metabolomics 1, 53\u201363 (2005).","journal-title":"Metabolomics"},{"key":"17921_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1039\/DC9868100117","volume":"81","author":"FM Go\u00f1i","year":"1986","unstructured":"Go\u00f1i, F. M. & Arrondo, J. L. R. A study of phospholipid phosphate groups in model membranes by Fourier transform infrared spectroscopy. Faraday Discuss. Chem. Soc. 81, 117\u2013126 (1986).","journal-title":"Faraday Discuss. Chem. Soc."},{"key":"17921_CR34","first-page":"92","volume":"1","author":"B Worley","year":"2013","unstructured":"Worley, B. & Powers, R. Multivariate Analysis in Metabolomics. Curr. Metabolomics 1, 92\u2013107 (2013).","journal-title":"Curr. Metabolomics"},{"key":"17921_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/cem.2609","volume":"28","author":"RG Brereton","year":"2014","unstructured":"Brereton, R. G. & Lloyd, G. R. Partial least squares discriminant analysis: taking the magic away. J. Chemom. 28, 213\u2013225 (2014).","journal-title":"J. Chemom."},{"key":"17921_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197\u2013203 (2011).","journal-title":"Nature"},{"key":"17921_CR37","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","volume":"72","author":"M Platten","year":"2012","unstructured":"Platten, M., Wick, W. & Van den Eynde, B. J. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 72, 5435\u20135440 (2012).","journal-title":"Cancer Res."},{"key":"17921_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/hel.12174","volume":"20","author":"T Larussa","year":"2015","unstructured":"Larussa, T. et al. Enhanced Expression of Indoleamine 2,3-Dioxygenase in Helicobacter pylori-Infected Human Gastric Mucosa Modulates Th1\/Th2 Pathway and Interleukin 17 Production. Helicobacter 20, 41\u201348 (2015).","journal-title":"Helicobacter"},{"key":"17921_CR39","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcn\/81.5.1142","volume":"81","author":"YLJ Vissers","year":"2005","unstructured":"Vissers, Y. L. J. et al. Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am. J. Clin. Nutr. 81, 1142\u20131146 (2005).","journal-title":"Am. J. Clin. Nutr."},{"key":"17921_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.bbapap.2004.09.003","volume":"1703","author":"J Moskovitz","year":"2005","unstructured":"Moskovitz, J. Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim. Biophys. Acta 1703, 213\u2013219 (2005).","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17921-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T17:54:19Z","timestamp":1719683659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17921-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17921"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17921-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"12 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17774"}}